| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital
and2 Department of Medical Biochemistry, Göteborg University, S-413 45 Gothenburg, Sweden
Expression of the Epstein—Barr virus (EBV) latent membrane protein (LMP1) is regulated by virus- and host cell-specific factors. The EBV nuclear antigen 2 (EBNA2) has been shown to transactivate a number of viral and cellular gene promoters including the promoter for the LMP1 gene. EBNA2 is targeted to at least some of these promoters by interacting with a cellular DNA binding protein, RBP-J
. In the present report we confirm and extend our previous observation that the LMP1 promoter can be activated by EBNA2 in the absence of the RBP-J-binding sequence in the LMP1 promoter regulatory region (LRS). We show that two distinct LRS regions, -106 to +40 and -176 to -136, contribute to EBNA2 responsiveness. Site-directed mutagenesis analysis of the upstream -176/-136 EBNA2 responsive element revealed that two critical cis-acting elements are required for full promoter function. These same elements analysed by electrophoretic mobility shift assays define two binding sites recognized by nuclear factors derived from B cells. An octamer-like sequence (-147 to -139) contained overlapping binding sites for an unidentified transcriptional repressor on the one hand and a factor(s) belonging to the POU domain family but distinct from Oct-1 and Oct-2 on the other. An adjacent purine tract (-171 to -155) held a PU.1 binding site, which was also recognized by a related factor. The results suggest that the POU domain protein and either of two PU box-binding factors bind simultaneously to LRS, creating a ternary complex that might be in part responsible for mediating the transactivation of the LMP1 promoter by EBNA2. There were no qualitative differences between EBV-negative and EBV-positive cells with regard to transcription factor binding to the octamer-like sequence and the PU.1 recognition site, as revealed by electrophoretic mobility shift assays.
* Author for correspondence. Fax +46 31 828458. e-mail lars.rymo@ss.gu.se
Received 29 March 1995;
accepted 9 June 1995.
This article has been cited by other articles:
|
|
 |
|
  W. Lucchesi, G. Brady, O. Dittrich-Breiholz, M. Kracht, R. Russ, and P. J. Farrell Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 J. Virol., August 1, 2008; 82(15): 7456 - 7466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ning, L. E. Huye, and J. S. Pagano Interferon Regulatory Factor 5 Represses Expression of the Epstein-Barr Virus Oncoprotein LMP1: Braking of the IRF7/LMP1 Regulatory Circuit J. Virol., September 15, 2005; 79(18): 11671 - 11676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, J. Huang, F. Y. Wu, G. Liao, L. Hutt-Fletcher, and S. D. Hayward Regulation of Expression of the Epstein-Barr Virus BamHI-A Rightward Transcripts J. Virol., February 1, 2005; 79(3): 1724 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. West, H. M. Webb, A. J. Sinclair, and D. N. Woolfson Biophysical and Mutational Analysis of the Putative bZIP Domain of Epstein-Barr Virus EBNA 3C J. Virol., September 1, 2004; 78(17): 9431 - 9445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kwiatkowski, S. Y. J. Chen, and W. H. Schubach CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation J. Virol., June 1, 2004; 78(11): 6067 - 6072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yue, M. G. Davenport, J. Shackelford, and J. S. Pagano Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function J. Virol., April 1, 2004; 78(7): 3542 - 3552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ning, A. M. Hahn, L. E. Huye, and J. S. Pagano Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit J. Virol., September 1, 2003; 77(17): 9359 - 9368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dudziak, A. Kieser, U. Dirmeier, F. Nimmerjahn, S. Berchtold, A. Steinkasserer, G. Marschall, W. Hammerschmidt, G. Laux, and G. W. Bornkamm Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-{kappa}B Signaling Pathway J. Virol., August 1, 2003; 77(15): 8290 - 8298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Alazard, H. Gruffat, E. Hiriart, A. Sergeant, and E. Manet Differential Hyperacetylation of Histones H3 and H4 upon Promoter-Specific Recruitment of EBNA2 in Epstein-Barr Virus Chromatin J. Virol., July 15, 2003; 77(14): 8166 - 8172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dufva, J. Flodin, A. Nerstedt, U. Ruetschi, and L. Rymo Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation Nucleic Acids Res., May 15, 2002; 30(10): 2131 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Han, Y. Xue, S. Harada, S. Orstavik, B. Skalhegg, and E. Kieff Protein Kinase A Associates with HA95 and Affects Transcriptional Coactivation by Epstein-Barr Virus Nuclear Proteins Mol. Cell. Biol., April 1, 2002; 22(7): 2136 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Groves, M. A. Cotter, C. Subramanian, and E. S. Robertson The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters J. Virol., October 1, 2001; 75(19): 9446 - 9457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H. H. Niller Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus J. Virol., March 15, 2001; 75(6): 2584 - 2596. [Abstract] [Full Text]
|
|
|
|
|
|
B. Zhao and C. E. Sample Epstein-Barr Virus Nuclear Antigen 3C Activates the Latent Membrane Protein 1 Promoter in the Presence of Epstein-Barr Virus Nuclear Antigen 2 through Sequences Encompassing an Spi-1/Spi-B Binding Site J. Virol., June 1, 2000; 74(11): 5151 - 5160. [Abstract] [Full Text]
|
|
|
|
|
|
M. Cotter, J. Callahan, J. Aster, and E. Robertson Intracellular Forms of Human NOTCH1 Functionally Activate Essential Epstein-Barr Virus Major Latent Promoters in the Burkitt's Lymphoma BJAB Cell Line but Repress These Promoters in Jurkat Cells J. Virol., February 1, 2000; 74(3): 1486 - 1494. [Abstract] [Full Text]
|
|
|
|
|
|
C. Kaiser, G. Laux, D. Eick, N. Jochner, G. W. Bornkamm, and B. Kempkes The Proto-Oncogene c-myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2 J. Virol., May 1, 1999; 73(5): 4481 - 4484. [Abstract] [Full Text]
|
|
|
|
|
|
A. Sjöblom-Hallén, W. Yang, A. Jansson, and L. Rymo Silencing of the Epstein-Barr Virus Latent Membrane Protein 1 Gene by the Max-Mad1-mSin3A Modulator of Chromatin Structure J. Virol., April 1, 1999; 73(4): 2983 - 2993. [Abstract] [Full Text]
|
|
|
|
|
|
S. Harada, R. Yalamanchili, and E. Kieff Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation J. Virol., December 1, 1998; 72(12): 9948 - 9954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. I. Falk, L. Szekely, A. Aleman, and I. Ernberg Specific Methylation Patterns in Two Control Regions of Epstein-Barr Virus Latency: the LMP-1-Coding Upstream Regulatory Region and an Origin of DNA Replication (oriP) J. Virol., April 1, 1998; 72(4): 2969 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sjoblom, W. Yang, L. Palmqvist, A. Jansson, and L. Rymo An ATF/CRE Element Mediates both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter J. Virol., February 1, 1998; 72(2): 1365 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Fuentes-Panana and P. D. Ling Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation J. Virol., January 1, 1998; 72(1): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. van Leeuwen, M. Rensen, and P. C. van der Vliet The Oct-1 POU Homeodomain Stabilizes the Adenovirus Preinitiation Complex via a Direct Interaction with the Priming Protein and Is Displaced when the Replication Fork Passes J. Biol. Chem., February 7, 1997; 272(6): 3398 - 3405. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
